美国LaysanBio
聚乙二醇类

Laysan Bio is a drug delivery company offering quality activated polyethylene glycol products for use in therapeutics, devices and diagnostics.

If you have previously worked with PEG reagents give Laysan Bio a chance to show you how we can help. If you are currently considering using PEG reagents for the first time, give us a call and we will help you get started. Our PEG reagent catalog includes reagents that can be used in all of your research involving pegylation technology.

Laysan Bio, Inc. (Laysan) is a Biotechnology company that offers novel polymers to customers for development of a wide variety of platforms. We supply catalog and custom activated poly(ethylene glycol) reagents to Academics, Research Centers, Biotech and Pharmaceutical development companies. Laysan sells a large variety of activated polymers accompanied with prompt customer service and technical assistance. Laysan has been in business since July 2006 and has shown steady growth since inception. The management team and key employees have been involved with the development and supply of PEG reagents for seven FDA or EU approved drug products or medical devices including Neulasta?, Somavert?, PEGASYS?, PEG-INTRON?, Definity?, Macugen? and DuraSeal?. Our current staff has substantial experience in process development, scale up, compliant manufacturing, validation and program management to support our customer?s developmental and commercial programs. Eight of the current fourteen employees have nine plus years of experience in developing, manufacturing and managing the PEG reagents used in the listed programs. We are also working with other technology companies to allow Laysan to manufacture and distribute new novel polymers that compliment the existing poly(ethylene glycol) reagents we already offer.

Laysan currently offers activated PEG reagents made in our small scale production laboratory with batch sizes ranging from 100g up to 1Kg. Laysan is in the process of constructing a facility to house the catalog, custom, R&D and large scale production groups as well as a compliant manufacturing department. Construction of the facility began in March 2010 and is scheduled to be complete in July 2010. Compliant manufacturing is scheduled to begin in the new facility after commissioning in August 2010. The completion of the Tower Drive facility will allow Laysan to increase our production batch sizes up to 3Kg and allow us the opportunity to supply compliant ?Bulk Pharmaceutical Chemicals? for batches ranging from 100g up to a possible 20Kg batch size. Our current campus allows us land for future expansion to house larger manufacturing when required. A copy of our Quality Manual is available on request. Laysan is committed to support our customer?s requirements for activated polymers for their programs from conception through development to commercialization of their drug product or medical device. Laysan is ready to work with you in every way to ensure our product(s) fit your program requirements and we look forward to discussing this opportunity with you.